Communication with Patients with Hereditary Cancer: Practical Considerations Focusing on Women’s Cancers-Reference-Cited by-同舟云学术

Communication with Patients with Hereditary Cancer: Practical Considerations Focusing on Women’s Cancers

Published:2012-06-02 Issue: Volume: Page:207-214
ISSN:
Container-title:New Challenges in Communication with Cancer Patients
language:
Short-container-title:

Author:

Carapetyan Karen,Smith Julia,Muggia Franco

Publisher

Springer US

Link

http://link.springer.com/content/pdf/10.1007/978-1-4614-3369-9_17.pdf

Reference12 articles.

1. Smith J, Baer L, Blank S, Dilawari A, Carapetyan K, Alvear M, et al. A screening and prevention program serving an ethically diverse population of women at high risk of developing breast and/or ovarian cancer. Ecancermedicalscience. 2009;3:123.

2. Dilawari A, Cangiarella J, Smith J, Huang A, Downey A, Muggia F. Co-existence of breast and ovarian cancers in BRCA germ-line mutation carriers. Ecancermedicalscience; 2009.

3. Warner E. Impact of MRI surveillance and breast cancer detection in young women with BRCA mutation. Ann Oncol. 2011;22 Suppl 1:144–9.

4. Tan DSP, Rothermundt C, Thomas K, Bancroft E, Eeles R, Shanley S, et al. “BRCAness” syndrome in ovarian cancer: a case–control study describing the clinical features and outcome of patients with epithelial ovarian cancer associated with BRCA1 and BRCA2 mutations. J Clin Oncol. 2008;26:5530–6.

5. Safra T, Borgato L, Nicoletto MO, Rolnitzky L, Avraham SP, Geva R, et al. BRCA mutation status and determinant of outcome in women with recurrent epithelial ovarian cancer treated with pegylated liposomal doxorubicin. In: American Society of Clinical Oncology-National Cancer Institute-European Organisation for research and treatment of cancer annual meeting on molecular markers in cancer. Hollywood, FL, 18–20 Oct 2010.